FOXP2 and breast carcinoma: In breast cancer, MSCs potentiate stemness by inducing microRNA-199a and microRNA-214 expression in cancer cells, which have been shown to repress Forkhead box protein P2 (FOXP2) expression and thus enhance mammary CSC features.